Opposite effects of angiotensins receptors type 2 and type 4 on streptozotocin induced diabetes vascular alterations in mice. by M. Nasser et al.
Opposite effects of angiotensins receptors type 2 and type 4
on streptozotocin induced diabetes vascular alterations in
mice.
Submitted by Sébastien Faure on Wed, 04/09/2014 - 18:21
Titre Opposite effects of angiotensins receptors type 2 and type 4 on streptozotocininduced diabetes vascular alterations in mice.
Type de
publication Article de revue
Auteur Nasser, Mohamad [1], Clere, Nicolas [2], Botelle, Laurent [3], Javellaud, James [4],Oudart, Nicole [5], Faure, Sébastien [6], Achard, Jean-Michel [7]
Editeur BioMed Central











BACKGROUND: We examined the effect of chronic administration of angiotensin
IV (AngIV) on the vascular alterations induced by type 1 diabetes in mice.
METHODS: Diabetes was induced in adult Swiss mice with a single injection of
streptozotocin (STZ). Mice were treated subcutaneously with AngIV
(1.4 mg/kg/day) either immediately following diabetes induction (preventive
treatment), or treated with AngIV (0.01 to 1.4 mg/kg), alone or with the AT4
receptor antagonist Divalinal or the AT2 receptor antagonist PD123319, for two
weeks after 4 weeks of diabetes duration (rescue treatment). Acetylcholine-
induced, endothelium-dependent relaxation (EDR) was measured in isolated aortic
rings preparations. Histomorphometric measurements of the media thickness were
obtained, and nitric oxide (NO) and superoxide anion production were measured
by electron paramagnetic resonance in aorta and mesenteric arteries. The effect of
diabetes on mesenteric vascular alterations was also examined in genetically
modified mice lacking the AT2 receptor.
RESULTS: Induction of diabetes with STZ was associated with a progressive
decrease of EDR and an increase of the aortic and mesenteric media thickness
already significant after 4 weeks and peaking at week 6. Immediate treatment
with AngIV fully prevented the diabetes-induced endothelial dysfunction. Rescue
treatment with AngIV implemented after 4 weeks of diabetes dose-dependently
restored a normal endothelial function at week 6. AngIV blunted the thickening of
the aortic and mesenteric media, and reversed the diabetes-induced changes in
NO and O2•- production by the vessels. The protective effect of AngIV on
endothelial function was completely blunted by cotreatment with Divalinal, but not
with PD123319. In contrast, both the pharmacological blockade and genetic
deletion of the AT2 receptor reversed the diabetes-induced morphologic and
endothelial alteration caused by diabetes.
CONCLUSIONS: The results suggest an opposite contribution of AT2 and AT4
receptors to the vascular alterations caused by streptozotocin-induced diabetes in
mice, since chronic stimulation of AT4 by AngIV and inhibition of AT2 similarly
reverse diabetes-induced endothelial dysfunction and hypertrophic remodeling,
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